160 related articles for article (PubMed ID: 37366895)
1. Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor.
Evmorfopoulos K; Chasiotis G; Barbatis A; Zachos I; Kouvelos G; Bareka M; Vlachostergios PJ; Arnaoutoglou E; Tzortzis V; Matsagkas M
Curr Oncol; 2023 Jun; 30(6):5448-5455. PubMed ID: 37366895
[TBL] [Abstract][Full Text] [Related]
2. Successful emergency endovascular aortic repair for intratumoral hemorrhage in extensive retroperitoneal mass of testicular origin.
Hulova S; Aziri R; Vulev I; Palacka P; Kolnikova G; Rejlekova K; Chovanec M; Mardiak J; Pindak D; Mego M
BMC Surg; 2020 Nov; 20(1):272. PubMed ID: 33160340
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer.
Johnson SC; Smith ZL; Nottingham C; Schwen ZR; Thomas S; Fishman EK; Lee NJ; Pierorazio PM; Eggener SE
Urology; 2019 Jan; 123():186-190. PubMed ID: 30179635
[TBL] [Abstract][Full Text] [Related]
5. Robot-assisted laparoscopic retroperitoneal lymph node dissection with concomitant inferior vena cava thrombectomy for metastatic mixed testicular germ cell cancer: a case report.
Zhang K; Zhu G; Liu X; Tian J; Gu Y; Zhai M; Yang L; Liu W; Li H; Martinez Portillo FJ
J Med Case Rep; 2019 Aug; 13(1):272. PubMed ID: 31451109
[TBL] [Abstract][Full Text] [Related]
6. Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.
Johnston P; Beck SD; Cheng L; Masterson TA; Bihrle R; Kesler K; Foster RS
J Urol; 2013 Sep; 190(3):874-7. PubMed ID: 23517745
[TBL] [Abstract][Full Text] [Related]
7. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
8. Vena caval reconstruction during postchemotherapy retroperitoneal lymph node dissection for metastatic germ cell tumor.
Ehrlich Y; Kedar D; Zelikovski A; Konichezky M; Baniel J
Urology; 2009 Feb; 73(2):442.e17-9. PubMed ID: 18436290
[TBL] [Abstract][Full Text] [Related]
9. Retroperitoneal lymph node dissection with concomitant IVC thrombectomy, caval wall resection, and grafting for metastatic NSGCT.
Hakky T; Kim T; Rodriguez AR; Armstrong P; Mangar D; Spiess PE
Int Braz J Urol; 2012; 38(1):135; discussion 136. PubMed ID: 22397783
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
[TBL] [Abstract][Full Text] [Related]
11. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
[TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.
Luz MA; Kotb AF; Aldousari S; Brimo F; Tanguay S; Kassouf W; Aprikian AG
World J Surg Oncol; 2010 Nov; 8():97. PubMed ID: 21062470
[TBL] [Abstract][Full Text] [Related]
13. Postchemotherapy robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumors in the lateral decubitus position: oncological and functional outcomes.
Kordan Y; Köseoğlu E; Esen B; Özkan A; Kiremit MC; Kılıç M; Esen T
World J Urol; 2023 Apr; 41(4):1101-1107. PubMed ID: 36806014
[TBL] [Abstract][Full Text] [Related]
14. Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review.
Notarfrancesco M; Fankhauser CD; Lorch A; Ardizzone D; Helnwein S; Hoch D; Hermanns T; Thalmann G; Beyer J
Swiss Med Wkly; 2023 Apr; 153():40053. PubMed ID: 37080191
[TBL] [Abstract][Full Text] [Related]
15. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
[TBL] [Abstract][Full Text] [Related]
16. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
[TBL] [Abstract][Full Text] [Related]
17. [Caval involvement in advanced-stage non-seminoma testicular tumors: surgical strategy and long-term results].
Tavolini IM; Norcen M; Oliva G; Nigro F; Benedetto G; Mazzariol C; Bassi P
Arch Ital Urol Androl; 2002 Jun; 74(2):69-76. PubMed ID: 12161940
[TBL] [Abstract][Full Text] [Related]
18. Post-chemotherapy residual mass in non-seminomatous testicular cancer. The role of retroperitoneal lymph node dissection.
El Sayed S; Grando JP; Almeida SH; Mortati Neto N; Moreira HA
Int Braz J Urol; 2004; 30(5):384-8. PubMed ID: 15610570
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections.
Lloyd P; Hong A; Furrer MA; Lee EWY; Dev HS; Coret MH; Adshead JM; Baldwin P; Knight R; Shamash J; Alifrangis C; Stoneham S; Mazhar D; Wong H; Warren A; Tran B; Lawrentschuk N; Neal DE; Thomas BC
World J Urol; 2022 Jan; 40(1):119-126. PubMed ID: 34599350
[TBL] [Abstract][Full Text] [Related]
20. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
